RegulatoryJul 24, 2026, 07:31 AM
Dyadic Regains Nasdaq Compliance; Stock Continues Listing
AI Summary
Dyadic International announced that Nasdaq has confirmed the company has regained compliance with Nasdaq Listing Rules 5550(a)(2) and 5550(b). This resolution ensures that Dyadic's common stock will continue to be listed and traded on The Nasdaq Capital Market. CEO Mark Emalfarb stated that with this stability, the company will focus on executing its business strategy, developing products, expanding its protein production platforms, and advancing strategic collaborations.
Key Highlights
- Dyadic International regained compliance with Nasdaq Listing Rules 5550(a)(2) and 5550(b).
- The company's common stock will continue to be listed and traded on The Nasdaq Capital Market.
- CEO Mark Emalfarb expressed pleasure with the resolution, noting increased stability.
- Dyadic will focus on executing its business strategy and developing its own products.
- The company aims to expand commercial adoption of its C1 and Dapibus™ protein production platforms.
- Dyadic plans to advance strategic collaborations and create long-term shareholder value.
Price Impact
More from DYAI